COVID19 reagents
Ended Awarded Last action
- Contract number
- N6264520F0295
- Awardee
-
Gen-Probe Incorporated UEI QNXWLAJDL4J3
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $127,590
Award facts
- Opportunity
-
- Covid-19 Solicitation · N6264520Q0017 · Posted May 12, 2020
- Contract value 100% obligated
- $127,590.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Marlborough, MA 01752, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $127,590 |
About this award
This federal contract award is for COVID-19 REAGENTS and the APTIMA SARS-COV-2 ASSAY, awarded to Gen-Probe Incorporated, a medical diagnostics company that specializes in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal government. The $127,590.00 Firm Fixed Price contract was issued by the Defense Health Agency, a defense agency, on September 10, 2020, with a completion date of September 30, 2020. The contract was not set aside and is part of Gen-Probe's broader supply of COVID-19 testing supplies and services to various federal agencies, including the Defense Health Agency, Department of the Army Medical Command, Department of Veterans Affairs, and Department of the Navy Bureau of Medicine and Surgery, through Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs). These vehicles allow agencies to rapidly procure critical molecular diagnostic products from Gen-Probe to support ongoing healthcare and pandemic response efforts for military personnel, veterans, and their families.
Quick answers
Who was awarded contract N6264520F0295?
N6264520F0295 was awarded to Gen-Probe Incorporated by Bureau of Medicine and Surgery (Department of the Navy) on September 10, 2020.
How much is contract N6264520F0295 worth?
The government has obligated $127,590 on N6264520F0295.
Which agency awarded contract N6264520F0295?
Bureau of Medicine and Surgery (Department of the Navy) awarded N6264520F0295, with funding from Defense Health Agency (Department of Defense).
Is contract N6264520F0295 an order under another contract?
Yes. N6264520F0295 is a delivery order under N6264520D5007, an indefinite delivery contract.
Was contract N6264520F0295 competed?
The extent of competition for N6264520F0295 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award